The Anti-Coagulation Video Channel* is intended for primary care practitioners and specialists involved in the treatment and follow up care of patients with atrial fibrillation (AF) or venous thromboembolism (VTE). It provides an overview of how to prevent stroke and systemic embolism in nonvalvular AF patients and how to prevent and treat VTE.
Users can expect to find the following videos readily available on the video channel with regular updates:
The benefits of dabigatran in preventing stroke in atrial fibrillation patients (Hans-Christoph Diener, Gregory YH Lip and John Eikelboom)
Dabigatran for the treatment and prevention of DVT and PE (Samuel Z Goldhaber)
The safety profile of dabigatran (Hans-Christoph Diener, John Eikelboom and Jeffrey Weitz)
Healthcare professionals should return often to avoid missing out on new content.
*The Anti-Coagulation Video Channel has been supported by an educational grant from Boehringer Ingelheim, who provided the videos, and is intended for healthcare professionals outside the USA, Canada and UK.
The Thrombosis Educational Portal is intended for healthcare professionals involved in the treatment and management of venous and arterial thrombosis. This resource is organised around the following sections:
Acute Coronary Syndrome (ACS)
Users will also have access to a newsletters section, which is updated on a quarterly basis with related thrombosis news content. The most recent edition from February 2015 contains an article written by Professor John Camm, Professor of Clinical Cardiology at St George’s, University of London and Imperial College London titled ‘Extending the Clinical Utility of Novel Oral Anticoagulants’.
This resource is intended to provide information to an international audience outside of the UK and the USA.
Heart failure (HF) is a complex disorder whereby the heart becomes progressively unable to pump blood efficiently to the tissues of the body. The Heart Failure Knowledge Centre focuses on the pathophysiology, diagnosis and management of chronic and post myocardial infarction (post-MI) heart failure.
Risk factors for ACS, and subsequently post-MI heart failure, are usually the clinical consequence of the formation of an occlusive thrombus at the site of a ruptured or eroded atherosclerotic plaque in a coronary artery. These can be modifiable (smoking,1 obesity,1 lack of exercise,1 hypertension,1,2 hyperlipidaemia,2,3 diabetes mellitus3) and non-modifiable (increased age1, male gender1, family history1,2) risk-factors.
The Heart Failure Knowledge Centre aims to provides healthcare professionals with the tools to diagnose and manage patients with both chronic and post-MI heart failure in line with current ESC guidelines.
Kumar P, Clark M. Clinical medicine. 7th ed. Edinburgh: Saunders Elsevier, 2009.
Graham I, Atar D, Borch-Johnsen K, et al. European guidelines on cardiovascular disease prevention in clinical practice: executive summary. Eur J Cardiovasc Prevent Rehab 2007;14 Suppl. 2:E1-40.
Zeljko Reiner, Alberico L. Catapano, Guy De Backer et al. ESC/EAS Guidelines for the management of dyslipidaemias: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). Eur Heart J first published online June 28, 2011 doi:10.1093/eurheartj/ehr158.
Decisions to start cardiopulmonary resuscitation (CPR), or to decide in advance to issue a "do not attempt (cardiopulmonary) resuscitation" (DNAR) notice have always been a hot topic in clinical medicine. It may have become even more so since a recent (June 2014) court decision. This post discusses some of the issues and legalities around DNAR decisions.
Pulmonary hypertension (PH) is a pathophysiological disorder that may involve multiple clinical..
... conditions and can complicate the majority of cardiovascular and respiratory diseases. The composition of the guidelines task force reflects themultidisciplinary nature of PH, including members of different medical societies, associations and working groups. The current document follows the two previous ESC and ERS Guidelines, published in 2004 and 2009, focusing on clinical management of PH. A systematic literature review was performed from MEDLINEw to identify new studies published since 2009 concerning the topic of PH. Task force members selected studies based on relevance and appropriateness.
After completing this module you should be able to: describe the classification of bradycardias, describe the common causes of different types of bradycardia, and recognise typical electrocardiograms (ECGs).
Abdominal obesity is a major risk factor for heart attack, stroke, peripheral vascular disease, dementia, cancer and Type 2 diabetes. The central hypothesis for this proposal is that pro-atherogenic ...
Slides from ESOT 2015 are now available to view and download free of charge in the congresses section of the Anti-Infectives Knowledge
Network – Invasive Fungal Infections. Discussions focus on managing infection in solid organ transplantation.
November 2015 MYC/15/0052/EU